Literature DB >> 1260137

Hemoglobin pyrgos alpha2 beta2 83 (EF7) Gly leads to Asp: a new hemoglobin variant in double heterozygosity with hemoglobin S.

B Tatsis, K Sofroniadou, C I Stergiopoulos.   

Abstract

An electrophoretically fast-moving hemoglobin variant was found to be present together with hemoglobin S, in the hemolysate of the rythrocytes of at 3-yr-old Greek boy. Electrophoresis of the parents' erythrocyte hemolysates revealed that the father was an AS heterozygote, while the mother was a carrier of the variant hemoglobin. A sibling was also found to be a carrier. The amount of the mutant hemoglobin in the peripheral blood of the propositus, his mother, and his brother was 62.2%, 52.5%, and 51.1%, respectively, as determined by column chromatography. The patients peripheral blood smear showed mild anisocytosis, microcytosis, and hypochromia. Similar but less pronounced red cell abnormalities were found in the other two carriers. Structural analysis of the variant hemoglobin revealed substitution of an aspartic acid for the glycine residue at the beta83 (EF7) position. This new hemoglobin was named hemoglobin Pyrgos. All the carriers of hemoglobin Pyrgos are clinically healthy, and there seems to be no interaction between hemoglobin Pyrgos and hemoglobin S as manifested clinically.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1260137

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  2 in total

1.  Triple heterozygosity of a hemoglobin variant: hemoglobin Pyrgos with other hemoglobinopathies.

Authors:  Arunee Jetsrisuparb; Kanokwan Sanchaisuriya; Goonnapa Fucharoen; Supan Fucharoen; Surapon Wiangnon; Patcharee Komwilaisak
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

2.  Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation.

Authors:  Martin K Safo; Tzu-Ping Ko; Eric R Schreiter; J Eric Russell
Journal:  J Mol Struct       Date:  2015-11-05       Impact factor: 3.196

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.